|
2008 CSHL 73rd Symposium on Control and Regulation of Stem Cells
|
1R13CA133980-01
|
$6,500
|
$6,500
|
STEWART, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
A Comprehensive Investigation of Viral-induced Lymphomagenesis
|
5R01CA121180-03
|
$267,494
|
$267,494
|
FISHER, SUSAN
|
UNIVERSITY OF ROCHESTER
|
|
A computer aided chromosome imaging technique for cancer diagnosis
|
5R01CA115320-03
|
$312,688
|
$203,247
|
Liu, Hong
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
A Data Resource for Analyzing Blood and Marrow Transplants
|
2U24CA076518-11
|
$582,752
|
$582,752
|
HOROWITZ, MARY
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A Genome Wide RNAi Vulnerability Map for Myeloma
|
1R01CA133115-01
|
$270,000
|
$270,000
|
STEWART, A
|
MAYO CLINIC COLL OF MED, MAYO CLINIC AZ
|
|
A Genome-Wide Association Study of Non-Hodgkin Lymphoma
|
5R01CA122663-03
|
$529,626
|
$529,626
|
Skibola, Christine
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Mediterranean Diet in for Colon Cancer Prevention
|
5R01CA120381-02
|
$367,050
|
$367,050
|
DJURIC, ZORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Novel Antibody Therapeutic for Multiple Myeloma
|
2R44CA105840-02A2
|
$279,125
|
$279,125
|
CHINTALACHARUVU, KOTESWARA
|
CHIMERIC TECHNOLOGIES, INC.
|
|
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
|
5R01CA107300-05
|
$270,281
|
$270,281
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
|
5R01CA129974-02
|
$324,900
|
$324,900
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INSTITUTE
|
|
A pilot study of lung cancer and hematopoietic malignancy in the Guangzhou, China
|
Z01 CP010120-10365
|
$31,369
|
$7,842
|
Hayes, Richard
|
DCEG (NCI)
|
|
A Pull-Push Strategy for Lymphoma Immunotherapy
|
5K08CA105064-05
|
$128,547
|
$128,547
|
Song, Wenru
|
BAYLOR RESEARCH INSTITUTE
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
Z01 SC 010356
|
$365,279
|
$255,696
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
5R01CA055577-15
|
$264,061
|
$264,061
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Standardized Nursing Intervention Protocol for HCT Patients
|
5R01CA107446-03
|
$416,424
|
$416,424
|
GRANT, MARCIA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Training Program in Cancer Biology
|
2T32CA009054-31A2
|
$409,929
|
$122,979
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
A2a receptor engagement promotes T cell tolerance
|
5R01CA114227-03
|
$254,392
|
$63,598
|
POWELL, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
$13,599
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
$32,500
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
$952,464
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic Training in Oncology at the University of North Carolina at Chapel Hill
|
1T32CA128590-01A1
|
$128,532
|
$128,532
|
GOLDBERG, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Activation of BCL-2 in Hematologic Malignancies
|
2R01CA056764-14A1
|
$290,500
|
$290,500
|
BOXER, LINDA
|
PALO ALTO INSTITUTE FOR RES & EDU, INC.
|
|
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
|
1P01CA128913-01A1
|
$1,670,604
|
$317,415
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$258,071
|
$258,072
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of the LMP-1 Protein of Epstein-Barr Virus
|
3R01CA095043-05S1
|
$46,501
|
$23,251
|
MARTIN, JENNIFER
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
Activation of the LMP-1 Protein of Epstein-Barr Virus
|
5R01CA095043-05
|
$231,698
|
$115,849
|
MARTIN, JENNIFER
|
UNIVERSITY OF COLORADO AT BOULDER
|
|
Activity & resistance of Gleevec in GI stromal tumors
|
5K23CA109060-05
|
$136,080
|
$20,412
|
TRENT, JONATHAN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adenocarcinoma of the Lung: role of NNK susceptibility
|
5R01CA055769-18
|
$582,839
|
$145,710
|
SPITZ, MARGARET
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
3R01CA085915-08S1
|
$51,498
|
$51,498
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
5R01CA085915-08
|
$311,663
|
$311,663
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-02
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adult Leukemia Research Center
|
3P01CA018029-33S1
|
$140,652
|
$140,652
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-33
|
$4,943,916
|
$4,943,916
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
|
2R44CA114126-02
|
$419,983
|
$419,983
|
Lim, Mark
|
AMBERGEN, INC
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
2U01CA096230-06
|
$718,223
|
$445,298
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-25
|
$432,500
|
$432,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S1
|
$249,599
|
$154,751
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S2
|
|
$0
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
3U01CA121947-03S3
|
$250,067
|
$155,042
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Corsortium
|
5U01CA121947-03
|
$3,732,363
|
$2,314,065
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
3R01CA105255-05S1
|
$53,605
|
$53,605
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
5R01CA105255-05
|
$265,114
|
$265,114
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
|
5R01CA128609-03
|
$300,246
|
$300,246
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Allogeneic T Cell Responses Against Renal Cell Carcinoma
|
5R01CA106512-05
|
$302,644
|
$302,644
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
ALPHAV INTEGRINS AND TUMOR ANGIOGENESIS
|
5R37CA050286-20
|
$446,134
|
$446,134
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Alternative Entry Mechanism for Pathogenic Retroviruses
|
5R01CA104266-05
|
$259,594
|
$259,594
|
CUNNINGHAM, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
An Animal Model for Kaposi's Sarcoma
|
5K08CA103858-05
|
$133,083
|
$133,083
|
PARSONS, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
An anti-CD74 MAb-drug conjugate for B-cell malignancies
|
2R44CA108083-02A2
|
$492,190
|
$492,190
|
GOVINDAN, SERENGULAM
|
IMMUNOMEDICS, INC.
|
|
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
|
5R01CA122658-02
|
$561,207
|
$140,302
|
KNOBF, M
|
YALE UNIVERSITY
|
|
Analysis of a murine model of the AML1-ETO translocation
|
5R01CA096798-05
|
$281,848
|
$281,848
|
KLUG, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
Total relevant funding to Hematology for this search: $482,375,634
|